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A B S T R A C T
This work reports on a large-scale potential neuropeptide activity screening in human gut microbiomes de-
posited in public databases. In our experimental approach, the sequences of the bioactive peptides collected in
the MAHMI database, mainly predicted as immunomodulatory or antitumoral, were crossed with those of the
neuroactive/digestive peptides. From 91,325,790 potential bioactive peptides, only 581 returned a match when
crossed against the 5949 neuroactive peptides from the NeuroPep database and the 15 digestive hormones.
Relevant bacterial taxa, such as Ruminococcus sp., Clostridium sp. were found among the main producers of the
matching sequences, and many of the matches corresponded to adiponectin and the hormone produced by
adipocites, which is involved in glucose homeostasis. These results show, for the ﬁrst time, the presence of
potentially bioactive peptides produced by gut microbiota members over the nervous cells, most notably,
peptides with already predicted immunomodulatory or anti-inﬂammatory activity. Classical (Lactobacillus sp.)
and next-generation (Faecalibacterium sp.) probiotics are shown to produce these peptides, which are proposed as
a potential mechanism of action of psychobiotics. Our previous experimental results showed that many of these
peptides were active when incubated with immune cells, such as dendritic cells, so their eﬀect over the nervous
system innervating the gut mucosa holds signiﬁcant potential and should be explored.
1. Introduction
The gut microbiota and the brain interact with each other through
several bidirectional signalling pathways clustered in the so-called gut-
brain axis, in which a number of cell types and neuroactive metabolites
act as messengers and play important mediator roles (Holzer, 2016).
Among them, neuropeptides are small proteinaceous substances pro-
duced by nervous cells, which are released in a regulated fashion and
act on neural lineages, such as neurons and glial cells, as well as non-
neuronal target cells, such as glandular or muscular cells (Burbach,
2010). It is well-known that a vast number of neuropeptides are pro-
duced by central and peripheral neurons alongside with endocrine cells
in the gastrointestinal tract and other endocrinologically active organs
(Burbach, 2010; Kastin, 2013; Strand, 1999). Neuropeptides such as
substance P, calcitonin gene-related peptide, neuropeptide Y (NPY),
vasoactive intestinal polypeptide, somatostatin and corticotropin-re-
leasing factor (CRF) are also likely to play a role in the bidirectional
gut-brain communication, inﬂuencing the activity of the gastro-
intestinal microbiota and their interaction through the gut-brain axis
(Holzer & Farzi, 2014). Other biologically active peptides, which are
released to the blood stream and depend on the presence/absence of
nutrients along the digestive tract, also function as gut hormones. Gut
hormones and neuropeptides form families of closely related peptides.
For example, the peptide YY (PYY) and the pancreatic polypeptide are
closely related with the neuropeptide Y (NPY) (Holzer, 2016). Given
that neuropeptides and gut hormones may target the same cell mem-
brane receptors, the two messenger roles often converge in the same or
similar biological implications.
The ﬁrst neuropeptide, i.e. substance P, was discovered by van Euler
and Gaddum in 1931 (Euler & Gaddum, 1931) and sequenced in 1971
(Chang, Leeman, & Niall, 1971). Since then, there has been a tre-
mendous increase in the number of identiﬁed neuropeptides. However,
there are only three neuropeptide databases publicly available, i.e.
Neuropeptides (Burbach, 2010), NeuroPedia (Kim, Bark, Hook, &
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Bandeira, 2011) and Neuropep (Wang et al., 2015) (Burbach, 2010;
Kim et al., 2011; Wang et al., 2015), of which the NeuroPep database
presents the most complete collection. The current version of NeuroPep
(Feb 10th 2015) holds 5949 non-redundant neuropeptides, originating
from 493 organisms and belonging to 65 diﬀerent neuropeptide fa-
milies (http://isyslab.info/NeuroPep/).
The gut microbiota is important for educating the immune system to
recognise foreign antigens and to tolerate commensal microbes and
other diet-derived molecules (Lathrop et al., 2011). The gut microbes
can modulate, tune and tame the host immune response (Sathyabama,
Khan, & Agrewala, 2014). Public databases, such as MAHMI, aim to
facilitate the work of those scientiﬁc teams researching molecular in-
teractions between the human host and the intestinal microbiota
(Blanco-Míguez, Gutiérrez-Jácome, Fdez-Riverola, Lourenço, &
Sánchez, 2017). Currently, the MAHMI database compiles 91,325,790
peptides, extracted from extracellular proteins of the human micro-
biome and selected according to their immunomodulatory or anti-
proliferative bioactivity potential.
In the context of the microbiota-gut-brain axis, neuropeptides such
as NPY have a distinctive impact on the immune function, within and
outside the gastrointestinal tract (Bedoui, von Hörsten, & Gebhardt,
2007; Dimitrijević & Stanojević, 2013; Peter Holzer, Reichmann, &
Farzi, 2012; Wheway, Herzog, & Mackay, 2007). Till date, to the best of
our knowledge, the potential existence of neuropeptides encrypted in
the proteins produced by human intestinal microbes has not been ex-
plored. This lack of information contrasts with existing knowledge on
other neurotransmitters produced by the human gut microbiota, such as
serotonine or GABA (Cryan & Dinan, 2012; Nicholson et al., 2012).
Within this scenario, our previous results showing the existence and
in vitro activity of immunomodulatory peptides encrypted in the human
gut metaproteome (Hidalgo-Cantabrana et al., 2017), motivated the
hereby exploration of neuropeptides encrypted in the protein comple-
ment of our human microbiome. In particular, the aim of this pro-
spective work was to conduct an in silico, large-scale screening of po-
tential neuroactive peptides encrypted in the human gut metaproteome.
Such analysis was based on the collection of bioactive peptides in the
MAHMI database and the collection of neuroactive peptides in the
NeuroPep database, complemented with a set of the major gut hor-
mones/peptides. Main results and future research avenues are discussed
in the next sections.
2. Materials and Methods
2.1. Neuropeptide and digestion hormones data retrieval
An in house script was used to retrieve the amino acid sequences of
the 5949 neuropeptides in the NeuroPep database (Wang et al., 2015)
(http://isyslab.info/NeuroPep/home.jsp). Associated record metadata,
such as the name of the neuropeptide, the source organism, neuro-
peptide family, and UniProt cross-reference (UniProt Consortium,
2018), were also retrieved. Moreover, a manual search in UniProt en-
abled the compilation of data on 17 digestive hormones. All data is
listed in Supplementary Material S1.
2.2. Bioactive peptides data retrieval
All sequence data from the potential bioactive section of the MAHMI
database (Blanco-Míguez et al., 2017) were retrieved upon email re-
quest to the authors. A total of 91,325,790 potential bioactive peptides
were available at the time of this study.
2.3. Sequence comparison
The 5949 neuropeptides were divided in two sets: a set of 283
neuropeptides from Homo sapiens and a set of 5665 neuropeptides ob-
tained from other organisms. Therefore, three amino acid BLAST
databases were created, one for each of these sets and a third database
for the digestive hormones. The three BLAST databases were created
using the makeblastdb command of the BLAST+ suite of commands
(Camacho et al., 2009). The -dbtype prot and -parse_seqids arguments
were speciﬁed for the correct generation of the databases.
The 91,325,790 potential bioactive peptides retrieved from the
MAHMI database were matched against the three previous databases
using the BLASTp alignment tool (Madden, 2013). Successful align-
ments, i.e. those with an expected value (e-value) less than 1e−5, are
shown in Supplementary Material S2. Additionally, Supplementary
Material S3 shows the same data with a similarity threshold value of
50%, with the aim to reduce non-functional false positive results in the
successful alignments.
2.4. Motif discovery
The Multiple Em for Motif Elicitation (MEME) Suite 5.0.3 (Bailey
et al., 2009) was employed to discover common motifs shared by the
predicted neuropeptides. Classic discovery mode was selected to ﬁnd
motifs between 6 and 50 amino acids length. The predicted motif is
presented in Supplementary Material S4.
2.5. Genus prediction
In order to predict the bacterial genus, the amino acid sequences
from the 581 predicted neuropeptide/encrypted peptides retrieved in
our analysis were aligned against the NCBI non-redundant database
(nr) (Pruitt, Tatusova, Brown, & Maglott, 2012) using BLASTp. Genus
prediction results are listed in Supplementary Material S5. Genera that
contribute to the pool of potential bioactive peptides in less than 1% are
shown in the Others group.
2.6. Enriched pathways identiﬁcation in genus producing potential
neuropeptides
The pathways enriched by genus producing potential neuropeptides
was investigated using the PICRUSt tool version 1.1.0 (Langille et al.,
2013). PICRUSt requires OTU abundances mapped to Greengenes OTU
IDs as input for the prediction. From the 62 genus predicted, only 33
were mapped to the Greengenes 15.3 database (McDonald et al., 2012).
Using a mock community from derived from a gut microbiota as control
sample, three synthetic communities were created enriching the re-
lative abundance of the neuroactive peptide producing genus. The
abundance of the predicted genus in these synthetic communities was
increased 2, 10 and 100 fold with respect to the OTU with greater re-
lative abundance in the control community (available as linked re-
search data). KEGG annotations were selected to report pathway pre-
dictions. Results of the three higher levels within the pathway hierarchy
were reported in Supplementary Material S6. Pathways with changes
greater than 0.3% were selected as signiﬁcative.
3. Results and discussion
The human intestinal microbiota plays a central role in regulating
not only proper immune system maturation, but also brain function
through interaction with the nervous system (Rao & Gershon, 2016;
Rooks & Garrett, 2016). Moreover, diﬀerent scientiﬁc studies have
identiﬁed microbiota-derived bioactive molecules, which exert their
immunomodulatory eﬀects in the gut mucosa as well as in relatively
distant body locations, such as the brain (Blander, Longman, Iliev,
Sonnenberg, & Artis, 2017). Among other, the following molecules are
worth of mention: i) the short chain fatty acids with anti-inﬂammatory
properties, such as butyrate, are produced through fermentative me-
tabolism from dietary ﬁbre by many Firmicutes; ii) the polysaccharide
A of Bacteroides fragilis has an impact on the expansion of Treg cell
populations; iii) the dipeptide aldehydes produced by anaerobe
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Firmicutes taxa, which interact with an uncharacterised chatepsin
target that blocks the function of the innate immune system; and, iv)
the S-layer protein from Lactobacillus acidophilus that interaction di-
rectly with dendritic cells promoting IL-10 production (Furusawa et al.,
2013; Guo et al., 2017; Lightfoot et al., 2015; Mazmanian, Round, &
Kasper, 2008). However, there is still little understanding about how a
given commensal microbiota modulates host-immune function. Many
of the molecular mechanisms of action by which these bacteria exert
immunomodulatory or other eﬀects remain unknown or poorly char-
acterised. This includes the potential presence of encrypted peptides in
the human gut metaproteome with neuroactive bioactivity once re-
leased by the action of gastrointestinal proteases. To our knowledge this
has not been explored so far.
Fig. 1 depicts the main results obtained after matching the potential
immunomodulatory and antitumoral peptides against the three re-
ference databases of i) human neuropeptides, ii) non-human neuro-
peptides and iii) digestive hormones. Only a very low percentage of the
MAHMI peptides, 581 out of more than 91 million peptides, could be
matched (Supplementary Material S2). In particular, 258 peptides got a
match in the human neuropeptide database (0.000283%), 313 in the
non-human neuropeptide database (0.000343%) and 10 in the group of
digestive hormones (0.000011%) (Fig. 1A). Considering homology, 202
peptides returned similarity values between 25 and 49% (34.77%), 365
of the values were in the range of 50–74% (62.82%) and only 14
peptides had similarity values between 75 and 100% (2.41%) (Fig. 1B).
Finally, the distribution of peptides by sequence length (Fig. 1C) and by
matched bioactivity (Fig. 1D) revealed some interesting patterns. For
example, most of the matches of potential immunomodulatory or anti-
inﬂammatory were related to human or non-human neuropeptides
(98%), even applying a similarity threshold of 50% (Supplementary
Material S3).
Fig. 2A represents the distribution of matched peptides according to
the intestinal bacteria genus that produces the source protein. An in-
teresting result is that the most important producers of potential
neuropeptides are members of the genera Ruminococcus (14%) and
Clostridium (10%), as well as an uncharacterised Firmicutes genus (7%).
These genera represent important and very abundant taxa (many not
yet cultured) of the human gut microbiota with the ability to expand
Treg cell populations, favouring intestinal homeostasis (Atarashi et al.,
2013). In the same way, other Firmicutes genera, such as Blautia sp. and
Faecalibacterium sp., are the source of 4% of the analysed bioactive
peptides. This is again important because species belonging to these
genera are butyrate producers, a well-known anti-inﬂammatory meta-
bolite that also favours intestinal homeostasis (Machiels et al., 2013).
Moreover, strains belonging to the genus Faecalibacterium often exhibit
decreased numbers in the framework of Inﬂammatory Bowel Disease
and, most notably, their absence is considered a biomarker of inﬂamed
mucosa (Sokol et al., 2008). Noteworthy, a healthy individual harbours
grams of bacteria belonging to the above mentioned Firmicutes genera.
Therefore, high local concentrations of these potential bioactive pep-
tides can be originated after the action of gastrointestinal endoproteases
over these gut bacteria. Surprisingly, Bacteroidetes, i.e. the genus from
the other main phyla of the human gut microbiota, showed a limited
percentage of bioactive peptides in the present analysis: Bacteroides sp.
3% and Prevotella 2%. Other interesting genera producing potential
neuroactive peptides are Lactobacillus (3%), Streptococcus (3%) and
Escherichia (2%).
An over-representation of these genera (10 or 100-fold) within a
mock microbiota produced changes in pathways related to metabolism,
cellular processes, and environmental and genetic information proces-
sing levels (Supplementary Material S6). Regarding to the metabolism
pathway level, the carbohydrate metabolism (1.1–1.2%) and the glycan
biosynthesis and metabolism were over-expressed (0.8%), while nu-
cleotide metabolism was found under-expressed (0.4%). At the cellular
processes pathway level, cell motility pathway was found under-ex-
pressed (0.9%). At the genetic information processing level, replication
and repair (1.2%), transcription (0.4%) and translation (0.6%) were
pathways were under-represented. Respecting the environmental
Fig. 1. Statistical results of the sequence comparison: (A) Number of hits by database; (B) Number of hits by homology percentage; (C) Number of hits by sequence
length; (D) Percentage of hits grouped by matched bioactivity. Notes for matched bioactivities: NH: Neuropeptides from Homo sapiens. NN: Neuropeptides from other
organisms. ANT: Anti-inﬂammatory. IMM: Immunomodulatory.
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information processing level, at the membrane transport level the
phosphotransferase system pathway was found over-represented
(0.4%), but transcription machinery (0.3–0.4%), ABC transporters
(0.6%-) transporters (0.9%) pathways were under-represented.
Moreover, the Sporulation pathway of the Cellular Process and
Signalling level was also under-represented (0.5%).
Some strains belonging to these genera, notably to the genus
Lactobacillus, are considered probiotics given the beneﬁcial eﬀects
shown over human health in clinical trials, and these include the so-
called psychobiotics (Dinan, Stanton, & Cryan, 2013). Psychobiotics are
deﬁned as live organisms that, when ingested in adequate amounts,
produce a health beneﬁt in patients suﬀering from psychiatric illness
(Dinan et al., 2013). Psychobiotics are known to produce neuro-
transmitters in the gut, such as gamma-aminobutyric acid and ser-
otonin, which are able to reach the nervous system and act on the brain-
gut axis (Rao & Gershon, 2016). Our results propose bacterial neuro-
peptides as additional molecular mediators of the mechanism of action
of psychobiotics.
Fig. 2B illustrated common bacterial genus between those produ-
cing potential neuropeptides (n=62) and those reported as under-re-
presented in neurological and psychiatric disorders (n=19) (Fung,
Olson, & Hsiao, 2017). Only microbiota changes at genus level are re-
trieved from the Fung et al. review. Coprococcus, Faecalibacterium,
Lactobacillus, Megamonas, Parabacteroides, Prevotella, Staphylococcus and
Streptococcus genus were found in both sets. However, a more severe
ﬁltering of the results applying a sequence similarity threshold of 50%,
revealed that matches belonging to Coprococcus and Parabacteroides
genus could be indeed non-functional false-positives (Supplementary
Material S3). These results suggest that the potential neuropeptides
produced by these bacteria genus might have a role on these disorders,
although this remains a merely speculative hypothesis that will require
extensive experimentation.
Interestingly, most of the immunomodulatory/anti-inﬂammatory
peptides were matched against adiponectin (235) and, in a much lower
extent, nicotinamide phosphoribosiltransferase (12). Other human
neuropeptides/gastric hormones with matches in the MAHMI database
are the kininogen-1 (5), the peptide YY (3), the angiotensinogen (3), the
leptin (2), the ﬁbroblast growth factor 1pad (2) and the glucagon-like
peptide 1 (1) (Table 1). Adiponectin is the main hormone secreted by
adipocytes; reduction on the levels of this peptide has been linked with
obesity-related and cardiovascular diseases (Achari & Jain, 2017).
Other cell types, such as myocytes, also secrete adiponectin. Adipo-
nectin circulates in diﬀerent molecular mass forms, with diﬀerent de-
gree of multimerisation, and its administration has been related to anti-
atherogenic/anti-inﬂammatory eﬀects (Fantuzzi, 2005). In some stu-
dies, administration of this peptide has also been linked to an insulin-
sensitising eﬀect and a decrease in body weight (Fonseca, 2003).
As can be seen in Fig. 2C, 202 out of the 235 diﬀerent predicted
neuropeptides shared a common motif of 21 amino acids length. Similar
results were obtained with a ClustalΩ alignment of the hits (Supple-
mentary Material S7). Of these 202 peptides, 168 matched against the
collagen-like domain of adiponectin (Supplementary Material S8).
Agreeing with the obtained motif, collagen-like proteins are constituted
by repetitions of the triplet Gly-X-Y, where Y is often a prolyl or lysyl
residue (Herbert, Williams, Cooper, & Brimble, 2012). Many collagen-
like proteins have shown biomedical potential as anticancer agents, in
particular as angiogenesis inhibitors. For example, the collagen-like
protein endostatin was developed as anticancer drug for non-small cell
lung cancer (O'Reilly et al., 1997). Adiponectin has been proposed as a
drug candidate for the treatment of liver disease, type II diabetes, hy-
pertension and other obesity-related disorders such as obesity-related
breast cancer (Matsuzawa, 2010; Shetty, Kusminski, & Scherer, 2009;
Trujillo & Scherer, 2005; Wang et al., 2005; Wang, Xu, Knight, Xu, &
Cooper, 2002). Whether potential neuroactive peptides derived from
the gut microbiota might have complementary physiological roles to
those ascribed to adiponectin, will centre our scientiﬁc eﬀorts during
next years.
As a whole, the proposed in silico pipeline shows, for the ﬁrst time
ever, the presence of potential neuroactive peptides encrypted in the
proteomes of main members of the human gut microbiota, such as
Ruminococcus sp. or Clostridium sp., and in Lactobacillus sp., a genus
containing probiotic strains. Whether these peptides are able to mod-
ulate the function of neurons located in the gut mucosa can be only
hypothesised and will require further experimental testing, as we pre-
viously did for some immunomodulatory peptides encrypted also in the
human gut metaproteome (Hidalgo-Cantabrana et al., 2017).
4. Conclusions
This work presents a ﬁrst, in silico evidence of the existence of
peptides with a double bioactivity: neuropeptide or digestive-related,
and immunomodulatory or anti-inﬂammatory. Noteworthy, the
Fig. 2. Computational analysis of the genus producing potential neuropeptides: (A) Percentage of hits corresponding to potential neuroactive peptides grouped by
bacteria genus. “Others” group gathers genera with less than 3 hits. (B) Intersection between bacteria genus producing potential encrypted neuropeptides and genus
under-represented in neurological and psychiatric disorders. (C) Motif shared by 202 out of the 235 potential neuropeptides detected in our analysis.
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analysed peptides represent only a subset of the peptides generated
from the human gut metaproteome but are produced by meaningful
members of the gut microbiota that, for instance, are decreased in the
framework of inﬂammatory disorders. The potential eﬀect of these
peptides over the diﬀerent nervous cells that are located in the gut is
worthy of further deeper exploration and may lead to the interesting
and timely relevant conclusion that the human gut microbiota, and
most notably psychobiotics, might inﬂuence the host through the gut-
brain axis by shedding neuroactive peptides.
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